Professional Documents
Culture Documents
Khawasaki Disease
Khawasaki Disease
BACKGROUND AND OBJECTIVES: Kawasaki disease (KD) is the most common cause of childhood- abstract
acquired heart disease in developed countries. However, the etiology of KD is not known.
Aberrant immune responses are considered to play key roles in disease initiation and
breastfeeding can mature immune system in infants. We thus examined the association
between breastfeeding and the development of KD.
METHODS: We used a nationwide population-based longitudinal survey ongoing since 2010
and restricted participants to a total of 37630 children who had data on their feeding
during infancy. Infant feeding practice was queried at 6 to 7 months of age, and responses
to questions about hospital admission for KD during the period from 6 to 30 months of age
were used as outcome. We conducted logistic regression analyses controlling for child and
maternal factors with formula feeding without colostrum as our reference group.
RESULTS: A total of 232 hospital admissions were observed. Children who were breastfed
exclusively or partially were less likely to be hospitalized for KD compared with those
who were formula fed without colostrum; odds ratios for hospitalization were 0.26 (95%
confidence interval: 0.120.55) for exclusive breastfeeding and 0.27 (95% confidence
interval: 0.130.55) for partial breastfeeding. Although the risk reduction was not
statistically significant, feeding colostrum only also provided a protective effect.
CONCLUSIONS: We observed protective effects of breastfeeding on the development of
KD during the period from 6 to 30 months of age in a nationwide, population-based,
longitudinal survey in Japan, the country in which KD is most common.
aDepartment of Human Ecology, Okayama University Graduate School of Environmental and Life Science,
WHATS KNOWN ON THIS SUBJECT: Kawasaki
Okayama, Japan; and Departments of bPediatrics, and cEpidemiology, Okayama University Graduate School of disease (KD), an acute self-limiting systemic
Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan vasculitis, is the most common cause of childhood-
acquired heart disease in developed countries, but
Dr Yorifuji contributed to obtaining the data, the study design, data analysis and interpretation,
the etiology of the disease is unknown. Aberrant
and writing and revision of the manuscript; Dr Tsukahara contributed to the study design, data
immune responses are considered to play key roles
interpretation, and revision of the manuscript; Dr Doi contributed to the negotiation with the
Ministry of Health to obtain the data, interpreting the data, revision of the manuscript, and study in disease initiation.
supervision; and all authors approved the nal manuscript as submitted. WHAT THIS STUDY ADDS: We observed protective
DOI: 10.1542/peds.2015-3919 effects of breastfeeding on the development of KD
Accepted for publication Mar 8, 2016 during the period from 6 to 30 months of age in
Japan, the country in which KD is most common.
Address for correspondence to Takashi Yorifuji, MD, PhD, Department of Human Ecology, Okayama
University Graduate School of Environmental and Life Science, 3-1-1 Tsushima-naka, Kita-ku,
Okayama 700-8530, Japan. E-mail: yorichan@md.okayama-u.ac.jp
PEDIATRICS (ISSN Numbers: Print, 0031-4005; Online, 1098-4275).
To cite: Yorifuji T, Tsukahara H, Doi H. Breastfeeding and
Copyright 2016 by the American Academy of Pediatrics Risk of Kawasaki Disease: A Nationwide Longitudinal
Survey in Japan. Pediatrics. 2016;137(6):e20153919
using data from a nationwide, c Obtained from the rst survey (at age 6 mo).
d Obtained from the second survey (at age 18 mo).
population-based, longitudinal
survey in Japan. We then observed
that children who were breastfed We consider there to be at least 2 damage from an uncontrolled
exclusively or partially were less reasons for the protective effects inflammatory response.19 Breast
likely to be hospitalized for KD of breastfeeding on development milk contains numerous factors,
compared with those who were of KD. First, the mother may including allergens, which modulate
formula fed. Although the risk provide her own immunologic and promote immune system
reduction was not statistically memory (ie, antimicrobial factors development.10,11,21 Moreover,
significant, feeding colostrum only such as secretory immunoglobulin breast milk is considered to mature
also provided a protective effect. A, oligosaccharides, lactoferrin, the immune system through
The protective associations did nucleotides) to her infant via breast the establishment of intestinal
not change even after adjusting milk,19,20 which may prevent the microbiota.10,11 We observed
for an extensive list of potential infant from contracting infections protective effects of breastfeeding
confounders or in the sensitivity that trigger abnormal immune on the risk of hospital admission
analyses. This is the first study responses. Second, breastfeeding may excluding injuries, burn injuries,
examining the association between support the maturation of immune and fractures, which may indicate
breastfeeding and development system (ie, programming of the that breastfeeding has a generic
of KD. system),17 which may limit potential effect rather than a specific effect
Breastfeeding status
Formula feeding without colostrum 8/262 3.1 1 (reference) 1 (reference) 1 (reference)
Formula feeding with colostrum 7/583 1.2 0.39 (0.141.08) 0.39 (0.141.09) 0.39 (0.141.09)
Partial breastfeeding 139/17 097 0.8 0.26 (0.130.54) 0.27 (0.130.56) 0.27 (0.130.55)
Exclusive breastfeeding to 67 mo of age 78/9793 0.8 0.25 (0.120.53) 0.26 (0.120.54) 0.26 (0.120.55)
Breastfeeding duration
Formula feeding without colostrum 8/262 3.1 1 (reference) 1 (reference) 1 (reference)
Formula feeding with colostrum 7/583 1.2 0.39 (0.141.08) 0.39 (0.141.09) 0.39 (0.141.09)
Partial breastfeeding, breastfeeding duration, mo
12 20/2209 0.9 0.29 (0.130.67) 0.29 (0.130.67) 0.30 (0.130.68)
35 21/2689 0.8 0.25 (0.110.57) 0.25 (0.110.58) 0.26 (0.110.59)
67 98/12 199 0.8 0.26 (0.120.53) 0.27 (0.130.56) 0.26 (0.120.55)
Exclusive breastfeeding to 67 mo of age 78/9793 0.8 0.25 (0.120.53) 0.26 (0.120.54) 0.26 (0.120.55)
aAdjusted for childrens factors (gender, preterm birth, parity, singleton or multiple birth).
bAdjusted for childrens factors (gender, preterm birth, parity, singleton or multiple birth), maternal factors (maternal smoking status, maternal education, and maternal age category),
and residential area.
TABLE 4 Associations Between Breastfeeding Duration and KD Hospital Admission From 7 to 30 Months of Age, Using the Category of Formula Feeding
(Both With and Without Colostrum) as a Reference
KD Hospital % of OR (95% CI)
Admission/Total Hospital Model 1: Crude Model 2a Model 3b
Number Admission
Breastfeeding status
Formula feedingc 15/845 1.8 1 (reference) 1 (reference) 1 (reference)
Partial breastfeeding 139/17097 0.8 0.45 (0.270.78) 0.47 (0.270.80) 0.46 (0.270.79)
Exclusive breastfeeding at 67 mo of age 78/9793 0.8 0.44 (0.250.78) 0.45 (0.250.78) 0.45 (0.250.80)
Breastfeeding duration
Formula feedingc 15/845 1.8 1 (reference) 1 (reference) 1 (reference)
Partial breastfeeding, breastfeeding duration, mo
12 20/2209 0.9 0.51 (0.260.99) 0.51 (0.260.99) 0.51 (0.26 1.00)
35 21/2689 0.8 0.44 (0.220.85) 0.44 (0.220.85) 0.44 (0.230.87)
67 98/12 199 0.8 0.45 (0.260.78) 0.47 (0.270.81) 0.45 (0.260.79)
Exclusive breastfeeding at 67 mo of age 78/9793 0.8 0.44 (0.250.78) 0.45 (0.250.78) 0.45 (0.250.80)
a Adjusted for childrens factors (gender, preterm birth, parity, singleton or not).
b Adjusted for childrens factors (gender, preterm birth, parity, singleton or not), maternal factors (maternal smoking status, maternal education, and maternal age category), and
residential area.
c We combined the categories of formula feeding without colostrum and formula feeding with colostrum into a single category, formula feeding.
on KD. The protective effects of for 3 to 5 months, the magnitude representative sample, and roughly
breastfeeding on KD may be related of these effects reached a plateau, one-twentieth of the children born
to broad antiinfective functions of which means that breastfeeding for in 2010 were included in this survey.
breast milk. In addition, a previous at least 3 to 5 months, even together We thus had a relatively large
US cohort study suggested an with formula feeding, may provide number of KD cases, which allowed
increased risk of hospitalization some benefits. Moreover, although us to examine the dose-response
for any cause among children not statistically significant, feeding relationship between breastfeeding
who subsequently developed colostrum only also provided a and development of KD. In addition,
KD.9 Although it is impossible to protective effect. Colostrum, the the very high response rate at
draw a definite conclusion as to mammary secretion during the first baseline (88.1%) strengthens the
the underlying mechanism, these few days postpartum, also contains validity of our findings. The type and
observations may support the immunoglobulins and facilitates duration of feeding practices should
preceding theories. establishment of the intestinal be accurate because information
microbiota,22 which may provide on feeding was collected at the first
Interestingly, both exclusive and
some benefits in children.
partial breastfeeding had beneficial survey, when children were 6 to 7
effects on the development of KD. In The strength of the current months old. However, we could not
the category of partial breastfeeding study is that we had a nationally evaluate the effect of breastfeeding
FINANCIAL DISCLOSURE: The authors have indicated they have no nancial relationships relevant to this article to disclose.
FUNDING: Supported in part by a grant for Strategies for Efcient Operation of the University (2007030201).
POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conicts of interest to disclose.
REFERENCES
1. Son MBF, Newburger JW. Kawasaki lymph node syndrome 4. Dimitriades VR, Brown AG, Gedalia A.
disease. In: Kliegman R, Behrman RE, (MLNS) prevailing in Japan. Kawasaki disease: pathophysiology,
Nelson WE, editors. Nelson Textbook of Pediatrics. 1974;54(3): clinical manifestations, and
Pediatrics. 20th ed. Philadelphia, PA: 271276 management. Curr Rheumatol Rep.
Elsevier; 2016; 12091214 3. Greco A, De Virgilio A, Rizzo MI, et 2014;16(6):423
2. Kawasaki T, Kosaki F, Okawa S, al. Kawasaki disease: an evolving 5. Burns JC, Glod MP.
Shigematsu I, Yanagawa H. A new paradigm. Autoimmun Rev. Kawasaki syndrome. Lancet.
infantile acute febrile mucocutaneous 2015;14(8):703709 2004;364(9433):533544
The online version of this article, along with updated information and services, is
located on the World Wide Web at:
/content/137/6/e20153919.full.html